Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies ; volume:14 ; number:1 ; day:3 ; month:12 ; year:2024 ; pages:1-10 ; date:12.2024
Blood cancer journal ; 14, Heft 1 (3.12.2024), 1-10, 12.2024
- Urheber
-
Tao, Zhongfei
Chyra, Zuzana
Kotulová, Jana
Celichowski, Piotr
Mihályová, Jana
Charvátová, Sandra
Hájek, Roman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-024-01193-6
- URN
-
urn:nbn:de:101:1-2502172129567.584594531533
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tao, Zhongfei
- Chyra, Zuzana
- Kotulová, Jana
- Celichowski, Piotr
- Mihályová, Jana
- Charvátová, Sandra
- Hájek, Roman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
The journey of CAR-T therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Engineering CAR-T cells
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
The journey of CAR-T therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Engineering CAR-T cells
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
The journey of CAR-T therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Engineering CAR-T cells
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies